Group One Trading’s Rosetta Genomics Ltd. ROSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-233
Closed -$3K 5223
2016
Q2
$3K Buy
233
+66
+40% +$940 ﹤0.01% 4407
2016
Q1
$2K Sell
167
-116
-41% -$1.48K ﹤0.01% 4409
2015
Q4
$4K Buy
283
+58
+26% +$1.25K ﹤0.01% 4445
2015
Q3
$7K Buy
+225
New +$7.67K ﹤0.01% 4435
2015
Q1
Sell
-100
Closed -$3K 5519
2014
Q4
$3K Buy
100
+50
+100% +$1.62K ﹤0.01% 4642
2014
Q3
$2K Sell
50
-742
-94% -$33.7K ﹤0.01% 4972
2014
Q2
$41K Sell
792
-633
-44% -$31.3K ﹤0.01% 3681
2014
Q1
$85K Buy
1,425
+1,000
+235% +$51.6K ﹤0.01% 3216
2013
Q4
$15K Buy
+425
New +$14.8K ﹤0.01% 4420
2013
Q3
Sell
-417
Closed -$17K 5887
2013
Q2
$17K Buy
+417
New +$18.5K ﹤0.01% 4186

Other funds holding ROSG

Group One Trading's ROSG Position: Q1 2016 in Review

Group One Trading sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2016, closing a stake of 75 shares — an estimated $956 sold.

Group One Trading first reported a position in ROSG in Q2 2013 and held it in 8 quarters. The position peaked at $42K in Q2 2013. 10 funds tracked by Wall St. Rank hold ROSG as of Q1 2016.

  • Group One Trading reported no remaining Rosetta Genomics Ltd. position as of Q1 2016 after selling out during the quarter.
  • Group One Trading sold 75 Rosetta Genomics Ltd. shares in Q1 2016, an estimated $956.
  • Group One Trading first reported a position in Rosetta Genomics Ltd. in Q2 2013 and held it in 8 quarters.
  • Group One Trading's Rosetta Genomics Ltd. position peaked at $42K in Q2 2013.
  • 10 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2016.

Based on Group One Trading's 13F filing for Q1 2016, filed 12 May 2016.